Breast cancer is a heterogeneous disease encompassing a variety of entities with distinct
morphological features and clinical behaviors. Although morphology is often associated with …

Lopez‐Garcia MA, Geyer FC, Lacroix‐Triki M, Marchió C & Reis‐Filho JS (2010)
Histopathology 57, 171–192 Breast cancer precursors revisited: molecular features and …

Triple-negative breast cancer is viewed clinically as an aggressive subgroup of breast
cancer. In fact, most triple-negative breast cancers are poor-prognosis tumors with a …

Triple-negative breast cancers (TNBCs), defined by lack of expression of estrogen receptor,
progesterone receptor and HER2, account for 12–17% of breast cancers and are clinically …

Adenoid cystic carcinoma (AdCC) is a tumour with myoepithelial differentiation and
characterised by the presence of a dual population of basaloid and luminal cells arranged in …

Triple negative breast cancer (TNBC) is a type of aggressive breast cancer lacking the
expression of estrogen receptors (ER), progesterone receptors (PR) and human epidermal …

Context.—Numerous immunohistochemical stains have been shown to exhibit exclusive or
preferential positivity in breast myoepithelial cells relative to their luminal/epithelial …

The physical sciences and engineering have introduced novel perspectives into the study of
cancer through model systems, tools, and metrics that enable integration of basic science …

Triple-negative breast cancer (TNBC) is an extremely diverse group of breast tumors, with
aggressive clinical behavior, higher rates of distant recurrence and worse overall survival …

The absence of a robust risk stratification tool for triple negative breast cancer (TNBC)
underlies imprecise and nonselective treatment of these patients with cytotoxic …